https://www.taxtmi.com/news?id=50733 The document reports a prospectively registered, multicenter randomized non-inferiority trial of PANVIS-A conducted under Good Clinical Practice. Results show non-inferior clinical and technical performance compared with manual procedures, comparable patient radiation and contrast exposure, and a substantial reduction in primary-operator radiation. The device had obtained national market authorization prior to publication, and the report frames ongoing iterative development and first-in-human work for successor systems within the regulatory lifecycle. en-us Mon, 28 Jul 2025 16:31:04 +0530 Mon, 28 Jul 2025 16:31:04 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=50733 The document reports a prospectively registered, multicenter randomized non-inferiority trial of PANVIS-A conducted under Good Clinical Practice. Results show non-inferior clinical and technical performance compared with manual procedures, comparable patient radiation and contrast exposure, and a substantial reduction in primary-operator radiation. The device had obtained national market authorization prior to publication, and the report frames ongoing iterative development and first-in-human work for successor systems within the regulatory lifecycle. News - Mon, 28 Jul 2025 16:31:04 +0530 https://www.taxtmi.com/news?id=50733